`

DOR BioPharma, Inc

Biotechnology Research

Specialities :
Pharmaceutical drug development
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About DOR BioPharma, Inc

What does Dor biopharma, inc do?+

DOR BioPharma, Inc. ( DOR ) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DORs lead product, orBec (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of allogeneic hematopoietic cell transplantation

What are Dor biopharma, inc's specialties? +

Pharmaceutical drug development

What is Dor biopharma, inc's industry? +

Dor biopharma, inc operates in the Biotechnology research industry.

What is Dor biopharma, inc's revenue? +

Dor biopharma, inc's revenue is 11m - 100m

What is Dor biopharma, inc's company size? +

Dor biopharma, inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.